vistabel, 4 unitati allergan/0,1 ml
allergan pharmaceuticals ireland ltd. - irlanda - toxina botulinica de tip a unui - pulb. pt. sol. inj. - 4 unitati allergan/0,1ml - miorelaxante periferice alte miorelaxante cu actiune periferica
vistabel, 4 unitati allergan/0,1 ml
allergan pharmaceuticals ireland ltd. - irlanda - toxina botulinica de tip a unui - pulb. pt. sol. inj. - 4 unitati allergan/0,1ml - miorelaxante periferice alte miorelaxante cu actiune periferica
doxorubicin ebewe" 2mg/ml"
ebewe pharma gmbh nfg. kg - austria - doxorubicinum - conc. pt. sol. perf. - 2mg/ml - antibiotice citotoxice si substante inrudite antracicline si substante inrudite
doxorubicina accord 2 mg/ml
accord healthcare limited - marea britanie - doxorubicinum - conc. pt. sol. perf. - 2mg/ml - antibiotice citotoxice si substante inrudite antracicline si substante inrudite
doxorubicina actavis 2 mg/ml
sindan - pharma s.r.l. - romania - doxorubicinum - conc. pt. sol. perf. - 2mg/ml - antibiotice citotoxice si substante inrudite antracicline si substante inrudite
doxorubicina accord 2 mg/ml
accord healthcare b.v. - olanda - doxorubicinum - conc. pt. sol. perf. - 2mg/ml - antibiotice citotoxice si substante inrudite antracicline si substante inrudite
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doxorubicină clorhidrat - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - agenți antineoplazici - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
btxa (botulinum toxin type a for therapy) 100 u liofilizat pentru soluţie injectabilă
hugh source (international) ltd - o toxina botulinică - liofilizat pentru soluţie injectabilă - 100 u
ambroxol clorhidrat 30 mg comprimate
centrul Ştiinţific de producere "uzina chimico-farmaceutică borsceagov" sap - haloperidolum - comprimate - 30 mg
xerdoxo 10 mg
krka, d.d., novo mesto - slovenia - rivaroxabanum - compr. film. - 10mg - antitrombotice inhibitori directi ai factorului xa